Fernández-Suárez HG, Blum-Grynberg B, Aguilar-Villalobos EJ, Bautista-Rodríguez H

Language: Spanish
References: 22
Page: 133-138
PDF size: 37.05 Kb.

ABSTRACT

Background: there are no reliable and valid instruments in Mexico for breast cancer patients. Our objective was to measure reliability and validity of a Spanish version of the FACT-B (Functional Assessment of Cancer Therapy-Breast) questionnaire in Mexican population.
Methods: the translation of the questionnaire was reviewed and minor changes were made. The instrument was applied to 142 patients recently diagnosed with breast cancer. It was applied to 105 for the second time, and to 75 for the third time. An analysis of item discrimination was made. The questionnaire’s reliability was determined by Cronbach’s alpha. Concurrent validity was determined by an analysis of correlations between the instrument’s scales and EORTC’s QLQ C-30 y BR-23 scales.
Results: the five FACT-B subscales were reliable, their alpha coefficients varied between 0.65 and 0.82. The entire scale obtained a value of 0.87. The correlation analysis between FACT-B and EORTC QLQ C-30 subscales indicated that the same construct was being evaluated.
Conclusions: FACT-B is a valid, reliable and sensitive instrument to measuring quality life in Mexican breast cancer patients.

REFERENCES

1. Holzner B, Kemler G, Kopp M, Moschen R, Schweligkofler H, Dunser M, et al. Quality of life in breast cancer patients –Not enough attention for longterm survivors? Psychosomatics 2005;42:(2):117-123.

2. Schwartzmann L. Calidad de vida relacionada con la salud: aspectos conceptuales. Ciencia y Enfermería 2003;9(2):921

3. Lara-Muñoz MC. Conceptualización y medición de la calidad de vida de los pacientes con cáncer. [Tesis doctoral]. México: UNAM y Hospital Universitario de Puebla, 1997.

4. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997;278(1):47-50.

5. Ganz PA. Quality of life and the patient with cancer. Individual and policy implications. Cancer 1994; 74(4 Suppl):1445-1452.

6. Gunnars B, Nygren P, Glimelius B. Assessment of quality of life during chemotherapy. Acta Oncologica 2001;40(2-3):175-184.

7. Sprangers MA Quality of life assessment in Oncology. Acta Oncologica 2002;41(3):229-237.

8. Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. UK: John Wiley & Sons; 2000.

9. Muldoon FM, Barger SD, Flory JD, Manuck SB. What are quality of life measurements measuring? BMJ 1998;316(7130):542-545.

10. Arraraz UJ, Arias de la Vega F, Manterota BA, Vera GR, Martínez AM, Salgado P, et al. Quality of life in patients with locally advanced head and neck cancer treated with chemotherapy. Comparison of two protocols using the EORTC questionnaires (QLQ-C-30, H&N35). Clin Transl Oncol 2005;7(9): 398-403

11. Bottomley A. The cancer patient and quality of life. Oncologist 2002;7(2):120-125.

12. Grau J. Calidad de vida y salud: problemas actuales en su investigación. [Tesis]. Instituto Superior de Ciencias Médicas de la Habana, Facultad de Ciencias Médicas Calixto García, 1997. Disponible en http://alapsa.org/boletin/art02_2htm

13. Velikova G, Booth L, Smith BA, Brown PM, Lynch P, Brown JM, et al. Measuring quality of life in routine oncology practice improves communication and patient wellbeing: a randomized controlled trial. J Clin Oncol 2004; 22(4):714-724.

14. Ganz PA. Quality of life and the patient with cancer. Individual and policy implications. Cancer 1994;74(4 Suppl):1445-1452.

15. Spitzer WO. State of science 1986: quality of life and functional status as target variables for research. J Chron Dis 1987;40(6):465-471.

16. Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WN. Who should measure quality of life, the doctor or the patient? Br J Cancer 1988;57(1):109-112.

17. Gunnars B, Nygren P, Glimelius B. Assessment of quality of life during chemotherapy. Acta Oncologica 2001;40(2-3):175-184.

18. Godwin PJ, Black JT, Bordeleau LJ, Ganz PA. Health related quality of life measurement in randomized clinical trials in breast cancer-taking stock. J Natl Cancer Inst 2003;95(4);263-281.

19. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, et al. Reability and validity of the functional assessment of cancer therapy –breast quality of life instrument. J Clin Oncol 1997;15(9): 974-986.

20. Fuentes PH. Propuesta de un cuestionario de calidad de vida (QOL) en pacientes mexicanos. Gac Mex Oncol 2005;4(2).34-41.

21. Aaranson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Nicole JD, et al. The European Organization for Research and Treatment of Cancer QLQ C-30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-376.

22. Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller LF, et al. The European Organization for Research and Treatment of Breast Cancer –specific quality of life questionnaire module: first results from a three-country field study. J Clin Oncol 1996;14(10):2756-2768.